RESEARCH TRIANGLE PARK, N.C., Feb. 8, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) will issue its fourth quarter and full year 2010 earnings release after the market closes on February 23, 2011. Due to the pending merger with Grifols, S.A., Talecris will not be hosting a conference call to discuss its fourth quarter and full year results.
About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.
SOURCE Talecris Biotherapeutics Holdings Corp.
